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Abstract Plasma membranes of the yeast, Can-
dida utilis, were solubilized with octyl-b-D-gluco-
pyranoside and a fraction enriched in the lactate
carrier was obtained with DEAE-Sepharose an-
ion-exchange chromatography, after elution with
0.4 M NaCl. The uptake of lactic acid into pro-
teoliposomes, containing the purified protein
fraction and cytochrome c oxidase, was depen-
dent on a proton-motive force and the transport
specificity was consistent with the one of C. utilis
intact cells. Overall, we have obtained a plasma
membrane fraction enriched in the lactate carrier
of C. utilis in which the transport properties were
preserved. Given the similarities between the
lactate transport of C. utilis and the one of
mammalian cells, this purified system could be
further explored to screen for specific lactate
inhibitors, with potential therapeutic applications.
Keywords Candida utilis Æ Functional
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Introduction
Proton-linked transport of monocarboxylates
across the plasma membrane of mammalian cells
is mediated by a group of membrane proteins
known as MonoCarboxylate Transporters
(MCTs). Based on sequence homologies, 14
members of the MCT family were identified.
From these, six were functionally characterized
and only MCT1–MCT4 catalyse proton-linked
lactate transport (Halestrap and Meredith 2004).
In yeasts, extensive work has been performed
concerning the characterization of monocarb-
oxylate transport (Casal and Lea˜o 1995; Ca´ssio
and Lea˜o 1993; Ca´ssio et al. 1987, 1993; Gero´s
et al. 2000a; Lea˜o and van Uden 1986) however,
to date, no association has been reported with
MCT related genes. In Sacharomyces cerevisiae a
gene named JEN 1, which belongs to the sialate-
proton symporter family, was associated with the
uptake of lactate and other monocarboxylates
(Casal et al. 1999; Soares-Silva et al. 2003), while
the MCT related genes identified in this yeast do
not appear to be involved in the uptake of
monocarboxylates (Makuc et al. 2001). However,
functional characterization of the monocarboxy-
late transport of the yeast Candida utilis, revealed
several similarities with the transport system of
mammalian cells. Similarly to MCT1–MCT4
(Halestrap and Meredith 2004) monocarboxylate
transport in C. utilis is a proton symport which
F. Baltazar (&) Æ C. Lea˜o
Life and Health Sciences Research Institute (ICVS),
School of Health Sciences, University of Minho, Braga,
Portugal
e-mail: fbaltazar@ecsaude.uminho.pt
F. Ca´ssio
Department of Biology, Biology Centre, University of
Minho, Braga, Portugal
Biotechnol Lett
DOI 10.1007/s10529-006-9088-5
123
ORIGINAL PAPER
Functional purification of the monocarboxylate transporter
of the yeast Candida utilis
Fa´tima Baltazar Æ Fernanda Ca´ssio Æ Cecı´lia Lea˜o
Received: 23 March 2006 / Accepted: 21 April 2006
 Springer Science+Business Media B.V. 2006
accepts lactate and pyruvate (Lea˜o and van Uden
1986; Ca´ssio and Lea˜o 1991, 1993; Ca´ssio et al.
1993), and is inhibited by known mammalian
MCT inhibitors, such as CHC (a-cyanohydroxy-
cinnamic acid) and DIDS (4,4¢ di-isothiocyano-
stilbene-2,2¢-disulfonic acid) (Gero´s et al. 2000b).
In addition, a polypeptide of approximately
40 kDa was associated with C. utilis lactate
transport (Gero´s et al. 2000b), which is within the
range of molecular weights identified for mam-
malian lactate transporters (Allen and Brooks
1994; Poole and Halestrap 1992, 1994).
In the present work, the plasma membrane
proteins of the yeast C. utilis were solubilized,
purified by DEAE-Sepharose chromatography
and the activity of the lactate carrier was recon-
stituted into liposomes. This allowed a more po-
sitive identification of the protein involved in the
lactate transport of C. utilis, which could also be
an important contribution to the biochemical and
genetic knowledge on lactate transport systems in
yeasts.
Materials and methods
Preparation and solubilization of plasma
membranes
Candida utilis PYCC 3092 was grown on medium
containing 0.5% lactic acid, pH 4.8 (Gero´s et al.
2000b) and plasma membranes were prepared as
described by Van Leeuwen et al. (1991). Mem-
brane proteins were solubilized based on the
procedure described by Allen and Brooks (1994).
The solubilization mixture was prepared by
addition of 1–2 mg of membrane protein to
the solubilization buffer with the following com-
position: 10–20 mg octyl-b-D-glucopyranoside
(octylglucoside), 10 mM potassium phosphate,
50 mM NaCl, 10% (v/v) glycerol, 2 mM benz-
amidine, 1 mM DTT, 0.1 mM PMSF, pH 7.4, in a
final volume of 1 ml.
L-[U-14C]Lactic acid binding to plasma
membranes and SDS-PAGE analysis
Unless otherwise stated, aliquots of plasma
membranes were incubated with 16.5 lM
L-[U-14C]lactic acid (3.7 Bq), pH 7.4, for 2 h at
30C, in the final volume of 40 ll, before SDS-
PAGE. At the end of the run, the lanes contain-
ing radioactive samples were used for counting of
radioactivity (Gero´s et al. 2000b). Non-radioac-
tive membrane protein lanes were stained for
protein with silver nitrate.
Fractionation of the solubilized plasma
membranes
The DEAE-Sepharose column (1 ml) was washed
with 10 mM potassium phosphate (pH 7.4) and
equilibrated in solubilization buffer (see above).
The solubilized plasma membranes (1 ml) were
loaded onto the column and the bound material
was eluted with a NaCl gradient of 0.2–1 M (in
solubilization buffer). The resulting protein frac-
tions were collected and tested for their capacity
to bind radioactive lactic acid (see above) and the
protein electrophoretic pattern was analysed by
SDS-PAGE with silver staining.
Preparation of proteoliposomes containing the
purified lactate carrier protein and lactate
transport assays
The incorporation of the solubilized membrane
proteins into liposomes was performed by dilu-
tion of the detergent, following the procedure
described by Matsushita et al. (1983). Prior to
transport assays, the proteoliposomes were
thawed at room temperature and bath-sonicated
for 10–20 s until clear. At zero time, 18.6 lM
L-[U-14C]lactic acid was added to 200 ll proteo-
liposomes pre-incubated at 26C and energization
was performed by addition of 15 mM ascorbate,
150 lM TMPD and 15 lM cytochrome c. Aliqu-
ots of 7.5 ll were withdrawn at suitable intervals
and diluted with 2 ml ice-cold 100 mM LiCl.
Samples were filtered on cellulose nitrate filters
(pore size 0.45 lm, Schleider & Schuell), washed
with 2 ml 100 mM LiCl and radioactivity was
measured as indicated above.
Miscellaneous techniques
Protein was assayed according to the Lowry
method using BSA as a standard. Isolation of
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cytochrome c oxidase from bovine heart and
determination of its activity was performed as
described previously (Gero´s et al. 1996). Phos-
phatidylethanolamine from E. coli was purified
according to Viitanen et al. (1986). Protein sam-
ples were concentrated in Microsep 10K centrif-
ugal devices (Pall, Life Sciences), following the
manufacturer’s instructions.
Results and discussion
We showed previously that the lactate transporter
of the plasma membrane of Candida utilis is able
to bind L-[U-14C]lactic acid, which can be ob-
served by a peak of radioactivity in SDS-PAGE
(Gero´s et al. 2000b) and this procedure was used
to follow the transporter during purification.
Thus, a first set of experiments was conducted to
establish the optimal conditions of L-[U-14C]lactic
acid binding to the yeast plasma membranes. As
can be depicted from Fig. 1, protein labelling
proved to be dependent on pH, time of incuba-
tion, concentration of L-[U-14C]lactic acid and
concentration of protein in the isolated plasma
membranes. Based on these results, we have
selected pH 7.4, 2 h incubation and 16.5 lM
L-[U-14C]lactic acid as incubation conditions for
further experiments.
Solubilization of plasma membranes from
C. utilis grown on lactic acid was conducted using
a selection of non-denaturing detergents, namely
octylglucoside, Triton X-100, and 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS). These detergents were tested for their
capacity to solubilize the yeast plasma membrane
proteins as well as for the preservation of the
carrier’s capacity to bind L-[U-14C]lactic acid (not
shown). Octylglucoside was ultimately selected
for further experiments because (i) it was able to
solubilize the lactate carrier, preserving its
capacity to bind radioactive lactate and (ii) its
high CMC facilitated its removal from the protein
mixtures, important for the preparation of pro-
teoliposomes.
Solubilized plasma membrane protein
fractionation was performed by ion exchange
chromatography, using both a cation exchanger
(SP-Sepharose) and an anion exchanger (DEAE-
Sepharose), with a gradient of 0.2–1 M NaCl.
Protein fractions were incubated with radioactive
lactic acid and analysed by SDS-PAGE. Purifi-
cation with SP-Sepharose was not possible since,
under the conditions used, the lactate carrier did
not bind to the column. On the other hand, most
of the membrane protein (about 85%) bound to
DEAE-Sepharose (not shown) and lactate carrier
was eluted with the NaCl gradient. This fact
suggests that most of the plasma membrane pro-
tein of C. utilis is negatively charged at pH 7.4.
The results of protein fractionation by DEAE-
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Fig. 1 Factors influencing the magnitude of the peak of
radioactivity resulting from binding of L-[U-14C]lactic acid
to the lactate carrier protein of C. utilis detected in SDS-
PAGE. (a) effect of pH (s) and time of incubation with
radioactive lactic acid (d); (b) effect of concentration of
radioactive lactic acid (n) and concentration of membrane
protein (h) on the magnitude of the radioactive peak.
Data points represent the radioactivity associated with the
lactate carrier. The standard mixture contained plasma
membranes (5 mg/ml) and 16.5 lM L-[U-14C]lactic acid
(3.7 kBq) in 10 mM Tris, 1 mM EDTA, at pH 7.4 and was
incubated for 2 h at 30C, in the final volume of 40 ll. KPi
was replaced by Mes and Bis–Tris when incubations were
performed at pH 5.6 and pH 6.5, respectively
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Sepharose are presented in Fig. 2. Despite the
fact that most of the solubilized plasma mem-
brane protein (about 60%), was eluted up to
0.2 M NaCl (not shown), binding of radioactive
lactic acid was only detected in the 0.4 M NaCl
fraction (Fig. 2, lane 5). Thus, this anion
exchanger allowed the purification of the lactate
transport system of C. utilis, which is in agree-
ment with the literature reporting the purification
of the lactate transporters of rat and rabbit ery-
throcytes using anion-exchange chromatography
(Poole and Halestrap 1992, 1994). As shown in
Fig. 2, the peak of radioactivity appears to be
associated with a protein molecular weight
around 30 kDa. This molecular weight is also
within the range reported for the plasma mem-
brane lactate carriers of rat hepatocytes (Welch
et al. 1984), rat and rabbit erythrocytes (Poole
and Halestrap 1992; Jennings and Adams-Lackey
1982) and rat skeletal muscle (McCullagh and
Bonen 1995). As can be seen in Fig. 2 (lane 5),
there are still other polypeptides of different
molecular weights, present in the lactate carrier
enriched fraction, however, at this point we can-
not discard their involvement in C. utilis lactate
transport. For example, catalytic activity and
plasma membrane translocation of MCT1 and
MCT4 requires a chaperone protein named
CD147, which exhibits several protein bands of
35–65 kDa in SDS-PAGE, characteristic of its
glycosylation states (Kirk et al. 2000).
In order to investigate if the lactate transporter
was still functional after purification, the 0.4 M
fraction was incorporated in an artificial E. coli
phospholipid bilayer, containing cytochrome c
oxidase, as the proton-motive-force generating
system. The resulting proteoliposomes were used
to follow the uptake of L-[U-14C]lactic acid along
time. Under these conditions, about 100% of the
protein was incorporated (data not shown). The
addition of suitable electron donors to the system
caused an increase of about 4-fold in the uptake
of radioactive lactic acid (Fig. 3). The uptake of
radioactive lactic acid in control proteoliposomes
without membrane protein, under the same con-
ditions, was negligible (data not shown). The
Fig. 2 Analysis of the membrane protein fractions after
separation by DEAE-Sepharose chromatography. The
chart on the left shows a representative result from an
experiment of L-[U-14C]lactic acid binding to the protein
fractions: solubilized plasma membranes (d), column flow
through (s), 0.2 M NaCl eluate (m), 0.4 M NaCl eluate
(n), 0.6 M NaCl eluate (h). Protein was incubated with
radioactive L-lactic acid followed by SDS-PAGE and gel
slicing. Data points represent the radioactivity present in
each gel slice. The gel on the right shows the electropho-
retic pattern of the protein eluted fractions: lane 1,
molecular-mass markers; lane 2, solubilized plasma mem-
branes; lane 3, DEAE-Sepharose flow through; lanes 4, 5
and 6 correspond to 0.2, 0.4 and 0.6 M NaCl column
eluates, respectively. Protein contents in lanes 2–6 were 5,
3.5, 5, 5 and 2.5 lg, respectively. The gel was stained with
silver nitrate
Fig. 3 Time-course uptake of L-[U-14C]lactic acid in
proteoliposomes containing the purified lactate carrier.
Uptake of radioactive lactic acid (18.6 lM) was performed
at pH 6.2 and 26C, either with (d) or without (s)
energization. For energization of the system, at t = 5 min,
15 mM ascorbate, 0.015 mM cytochrome c and 0.15 mM
TMPD, were added to the reaction mixture (proteolipo-
somes with radioactive acid). At the time indicated by the
arrow, 10 lM FCCP (D), 20 mM pyruvic acid (n) and
20 mM citric acid (h) were added
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addition of the protonophore FCCP at maximal
accumulation caused a rapid efflux of the accu-
mulated radioactive lactate (Fig. 3), suggesting
the involvement of proton-motive force in lactate
transport. The specificity of the lactate transport
system was investigated by the addition of either
pyruvic or citric acids to the proteoliposomes,
after accumulation of radioactive lactate. The
results showed that only pyruvate was able to
promote the efflux of radioactive lactate (Fig. 3),
consistent with the fact that the transporter in
either C. utilis intact cells (Lea˜o and van Uden
1986) or hybrid vesicles (Gero´s et al. 1996),
accepts lactate and other monocarboxylates but
not di- or tricarboxylates.
In summary, the present study represents a
successful solubilization and purification of the
lactate carrier from the plasma membranes of the
yeast C. utilis, in a functionally active form. Our
procedure can contribute to the identification of
the protein component(s) involved in lactate
transport in other yeast species. In addition, since
MCTs have a role in pathologies with high gly-
colytic activity (e.g. solid tumors), by promoting
the efflux of the accumulating organic acids (e.g.
lactic acid), specific inhibition of these transport-
ers would result in intracellular acidification,
leading to tumor cell apoptosis. Taking into
consideration the similarities between the lactate
transport system of C. utilis and the one of
mammalian cells, we believe that our yeast sys-
tem might be further explored to study mono-
carboxylate transport inhibition, and to screen for
MCT specific inhibitors with potential therapeutic
applications.
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